Literature DB >> 19362130

Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning.

T Sherrin1, T Blank, R Saravana, M Rayner, J Spiess, C Todorovic.   

Abstract

We have previously reported that repeated central administration of sub-anxiogenic doses of the corticotropin releasing factor 1 (CRF(1)) agonist Cortagine, termed "priming," elicits a phenotype of increased anxiety-like behaviors in the elevated plus maze (EPM) and open-field test, and enhanced retention of contextual conditioned fear in C57BL/6J mice. Observed behavioral changes were functionally coupled to CRF(1)-mediated elevated central cholecystokinin (CCK) tone in discrete brain regions. However, the changes in gene expression that mediated "priming"-induced behavioral and concurrent molecular changes in specific brain regions remained unknown. In the present study, a complementary DNA microarray analysis was used to investigate gene expression profiles in the hippocampus and prefrontal cortex (PFC) of C57BL/6J mice following the "priming" procedure. Here, we report that chronic stimulation of CRF(1), by i.c.v. administration of 10 ng Cortagine for five days, brought about alterations in the expression of a wide range of hippocampal (31 genes) and PFC (18 genes) genes, implicated in anxiety and aversive memory formation. These expression changes involved genes associated with signal transduction, neurotransmitter secretion, synaptic transmission, myelination, and others involved in the transport, biosynthesis, and binding of proteins. In particular, several genes of the protein kinase A (PKA) and protein kinase C (PKC) signaling cascades, known to be involved in synaptic plasticity, such as neurogranin, calmodulin 3, and the PKA regulatory subunit 1 b were found to be upregulated in the PFC and hippocampus of CRF(1) agonist "primed" mice. Moreover, we show pharmacologically that one of the newly implicated memory regulatory elements, diazepam-binding inhibitor (DBI) is functionally involved in hippocampus-dependent enhancement of contextual fear, a cardinal phenotypic feature of the "primed" mice. Finally, an interaction network mapping of the altered genes and their known interacting partners identified additional molecular candidates responsible for CRF(1)-mediated hypersensitive fear circuitry.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362130     DOI: 10.1016/j.neuroscience.2009.04.012

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Genome-wide association for fear conditioning in an advanced intercross mouse line.

Authors:  Clarissa C Parker; Greta Sokoloff; Riyan Cheng; Abraham A Palmer
Journal:  Behav Genet       Date:  2012-01-12       Impact factor: 2.805

2.  Subregion-Specific Impacts of Genetic Loss of Diazepam Binding Inhibitor on Synaptic Inhibition in the Murine Hippocampus.

Authors:  Connor D Courtney; Catherine A Christian
Journal:  Neuroscience       Date:  2018-07-19       Impact factor: 3.590

3.  Differential impacts on multiple forms of spatial and contextual memory in diazepam binding inhibitor knockout mice.

Authors:  Ammar L Ujjainwala; Connor D Courtney; Natalia M Wojnowski; Justin S Rhodes; Catherine A Christian
Journal:  J Neurosci Res       Date:  2019-01-25       Impact factor: 4.164

Review 4.  Approaching the genomics of risk-taking behavior.

Authors:  Alison M Bell
Journal:  Adv Genet       Date:  2010-01-13       Impact factor: 1.944

Review 5.  From benzodiazepines to fatty acids and beyond: revisiting the role of ACBP/DBI.

Authors:  Thierry Alquier; Catherine A Christian-Hinman; Julieta Alfonso; Nils J Færgeman
Journal:  Trends Endocrinol Metab       Date:  2021-09-23       Impact factor: 12.015

6.  Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms.

Authors:  H Le-Niculescu; Y Balaraman; S D Patel; M Ayalew; J Gupta; R Kuczenski; A Shekhar; N Schork; M A Geyer; A B Niculescu
Journal:  Transl Psychiatry       Date:  2011-05-24       Impact factor: 6.222

7.  Convergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism.

Authors:  H Le-Niculescu; N J Case; L Hulvershorn; S D Patel; D Bowker; J Gupta; R Bell; H J Edenberg; M T Tsuang; R Kuczenski; M A Geyer; Z A Rodd; A B Niculescu
Journal:  Transl Psychiatry       Date:  2011-04-26       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.